DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Mobilization of Mesenchymal Stem Cells During Liver Transplantation

Completed

Conditions: Liver Failure
Liver Neoplasm

Interventions: Procedure: blood samples

First Posted Date: 2015-09-23

Last Posted Date: 2018-10-16

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 35

Registration Number: NCT02557724

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

Evaluation of Micropore"s SpiraLith Absorbents

Completed

Conditions: Airway Management During Operative Procedure

Interventions: Device: Micropore SpiraLith
Device: Carbon Dioxide Absorbents
Drug: Sevoflurane

First Posted Date: 2015-09-15

Last Posted Date: 2022-04-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 186

Registration Number: NCT02550470

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Phase 2

Completed

Conditions: Invasive Breast Carcinoma
Ductal Breast Carcinoma In Situ
Progesterone Receptor Positive
Stage IA Breast Cancer
Estrogen Receptor Positive
Stage IB Breast Cancer
Stage IIA Breast Cancer

Interventions: Radiation: Accelerated Partial Breast Irradiation
Radiation: High-Dose Rate Brachytherapy
Other: Questionnaire Administration

First Posted Date: 2015-08-18

Last Posted Date: 2023-05-15

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 200

Registration Number: NCT02526498

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸
William Beaumont Hospital Research Institute, Royal Oak, Michigan, United States
🇺🇸
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

and more 7 locations

Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors

Not Applicable

Active, not recruiting

Conditions: Stage II Renal Cell Cancer
Stage IV Renal Cell Cancer
Stage I Renal Cell Cancer
Stage III Renal Cell Cancer

Interventions: Procedure: Arterial Spin Labeling Magnetic Resonance Imaging
Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
Procedure: Perfusion Magnetic Resonance Imaging

First Posted Date: 2015-08-18

Last Posted Date: 2023-04-11

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 75

Registration Number: NCT02526511

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Telephone-Based Counseling for Depression in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson's Disease
Depression

Interventions: Behavioral: TH-CBT
Other: Enhanced Usual Care

First Posted Date: 2015-07-22

Last Posted Date: 2019-02-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 72

Registration Number: NCT02505737

Locations: 🇺🇸
Rutgers University-Robert Wood Johnson Medical School, Piscataway, New Jersey, United States

Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Education of goal setting and achievement

First Posted Date: 2015-07-14

Last Posted Date: 2016-03-11

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 9

Registration Number: NCT02497170

Locations: 🇺🇸
Melissa Souza, Somerdale, New Jersey, United States

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Phase 1

Completed

Conditions: Metastatic Prostatic Adenocarcinoma
Metastatic Prostate Carcinoma
Prostate Carcinoma Metastatic to the Bone

Interventions: Procedure: Robotic Assisted Radical Prostatectomy
Procedure: Conventional open retropubic radical prostectomy
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Drug: ADT (androgen deprivation therapy) (i.e. leuprolide) plus an androgen receptor inhibitor (i.e. bicalutamide)

First Posted Date: 2015-06-01

Last Posted Date: 2021-04-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 26

Registration Number: NCT02458716

Locations: 🇺🇸
City of Hope National Medical Center (COH), Duarte, California, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
University of California, Irvine (UCI), Orange, California, United States

The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

Recruiting

Conditions: Microdeletion 3q29 Syndrome
Microduplication 3q29 Syndrome

First Posted Date: 2015-05-19

Last Posted Date: 2024-12-06

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 800

Registration Number: NCT02447861

Locations: 🇺🇸
Internet-Based, Piscataway, New Jersey, United States

Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance

Early Phase 1

Terminated

Conditions: Prostate Carcinoma

Interventions: Drug: Hydroxychloroquine
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-04-20

Last Posted Date: 2017-02-02

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 4

Registration Number: NCT02421575

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

Phase 2

Terminated

Conditions: Recurrent Prostate Carcinoma
Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer

Interventions: Drug: Aspirin
Other: Laboratory Biomarker Analysis
Other: Placebo
Drug: Metformin Hydrochloride

First Posted Date: 2015-04-20

Last Posted Date: 2023-02-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 27

Registration Number: NCT02420652

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy